Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ADMA Biologics Inc (NASDAQ:ADMA)

7.37
Delayed Data
As of 12:03pm ET
 +0.121 / +1.67%
Today’s Change
4.15
Today|||52-Week Range
9.96
-8.66%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2012

2013

2014

2015
AssetsCash--26.1M17.2M10.4M
 
 
 
 
Short Term Investment Cash12.4M13.6M-9.0M-6.8M
 
 
 
 
 
Cash & Short Term Investments12.5M29.1M21.9M16.8M
 
 
 
 
 
 
ReceivablesReceivables39.1K0.00384.0K924.5K
 
 
 
 
 
InventoriesInventories1.3M1.7M1.7M3.4M
 
 
 
 
 
 
Current AssetsPrepaid Expenses107.8K298.7K143.6K111.0K
 
 
 
 
 
Current Assets13.9M31.1M24.1M21.3M
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross1.6M1.8M4.1M4.2M
 
 
 
 
 
Depreciation-825.4K-1.0M-1.3M-1.8M
 
 
 
 
 
Other Assets376.0K162.2K298.8K27.2K
 
 
 
 
 
Total Assets15.6M32.0M27.2M23.7M
 
 
 
 
 
 
LiabilitiesAccounts Payable1.1M2.7M1.8M2.1M
 
 
 
 
 
Short Term Debt11.6K12.7K13.8K15.1K
 
 
 
 
 
Accrued Expenses747.1K860.1K2.3M2.0M
 
 
 
 
 
Other Current Liabilities747.1K935.7K2.4M2.1M
 
 
 
 
 
Other Liabilities1.8M3.7M4.2M4.2M
 
 
 
 
 
 
Total LiabilitiesLong Term Debt4.0M5.1M15.0M15.7M
 
 
 
 
 
Other Liabilities229.3K0.00476.8K0.00
 
 
 
Total Liabilities6.1M10.4M21.2M22.9M
 
 
 
 
 
 
EquityMinority Interest0.000.000.000.00--
Preferred Stock0.000.000.000.00--
Common Equity9.4M21.6M6.0M821.0K
 
 
 
 
 
Total Shareholder Equity9.4M21.6M6.0M821.0K
 
 
 
 
 
 
Share InformationCommon Shares Outstanding9.7M9.3M9.3M10.7M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.